Enzybiotics: Energizing antibiotics as an effective weapon in the fight against infections

· Emerging Technologies in Medical 7권 · One Billion Knowledgeable
eBook
280
페이지
적용 가능
검증되지 않은 평점과 리뷰입니다.  자세히 알아보기

eBook 정보

What Is Enzybiotics

Nelson, Loomis, and Fischetti were the ones who first characterized enzybiotics as a kind of experimental antibacterial treatment. The name is a portmanteau of the terms "enzyme" and "antibiotics," which were combined to form the term. Because of the antibacterial and antimicrobial qualities that they possess, enzymes have seen widespread use. Study on enzybiotics is based on proteolytic enzymes known as endolysins, which have shown to be particularly efficient in battling a variety of bacteria and serve as the foundation for this research. Endolysins are a very effective method of lysing bacterial cells. They are derived from bacteriophages and have a long history of use. The problem of antibiotic resistance, which has allowed for the spread of drug-resistant microorganisms that pose a huge danger to animal and human health around the world, is the primary motivation for the majority of the research being conducted on enzybiotics.


How You Will Benefit


(I) Insights, and validations about the following topics:


Chapter 1: Enzybiotics


Chapter 2: Antibiotic


Chapter 3: Antimicrobial resistance


Chapter 4: Staphylococcus aureus


Chapter 5: Methicillin-resistant Staphylococcus aureus


Chapter 6: Drug resistance


Chapter 7: Methicillin


Chapter 8: Phage therapy


Chapter 9: Tigecycline


Chapter 10: Flucloxacillin


Chapter 11: Dicloxacillin


Chapter 12: Oritavancin


Chapter 13: Lysin


Chapter 14: Lysostaphin


Chapter 15: Dalbavancin


Chapter 16: Arbekacin


Chapter 17: Ceftaroline fosamil


Chapter 18: Discovery and development of cephalosporins


Chapter 19: OBPgp279


Chapter 20: ESKAPE


Chapter 21: Multidrug-resistant bacteria


(II) Answering the public top questions about enzybiotics.


(III) Real world examples for the usage of enzybiotics in many fields.


(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of enzybiotics' technologies.


Who This Book Is For


Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of enzybiotics.

저자 정보

Fouad Sabry is the former Regional Head of Business Development for Applications at HP. Fouad has received his B.Sc. of Computer Systems and Automatic Control in 1996, dual master’s degrees from University of Melbourne (UoM) in Australia, Master of Business Administration (MBA) in 2008, and Master of Management in Information Technology (MMIT) in 2010. Fouad has more than 20 years of experience in Information Technology and Telecommunications fields, working in local, regional, and international companies, such as Vodafone and IBM. Fouad joined HP in 2013 and helped develop the software business in tens of markets. Currently, Fouad is an entrepreneur, author, futurist, focused on Emerging Technologies, and Industry Solutions, and founder of One Billion Knowledgeable (1BK) Initiative.

이 eBook 평가

의견을 알려주세요.

읽기 정보

스마트폰 및 태블릿
AndroidiPad/iPhoneGoogle Play 북 앱을 설치하세요. 계정과 자동으로 동기화되어 어디서나 온라인 또는 오프라인으로 책을 읽을 수 있습니다.
노트북 및 컴퓨터
컴퓨터의 웹브라우저를 사용하여 Google Play에서 구매한 오디오북을 들을 수 있습니다.
eReader 및 기타 기기
Kobo eReader 등의 eBook 리더기에서 읽으려면 파일을 다운로드하여 기기로 전송해야 합니다. 지원되는 eBook 리더기로 파일을 전송하려면 고객센터에서 자세한 안내를 따르세요.

시리즈 계속

Fouad Sabry 작가의 책 더보기

비슷한 eBook